Apalutamide-induced severe cutaneous adverse reactions in prostate cancer: a comprehensive review of reported cases and clinical strategies

PurposeProstate cancer (PCa) is the most common fatal malignancy among men and a major cause of cancer-related death. Apalutamide, a second-generation androgen receptor inhibitor, is approved for non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Taisong Wang, Shuang Liu, Renbin Yuan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-04-01
coleção:	Frontiers in Pharmacology
Assuntos:	androgen receptor antagonists apalutamide drug eruptions drug therapy prostatic neoplasms
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1769981/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!